Transforming Endovascular Aortic Arch Repair
With its innovative NEXUS™ Stent Graft System, Endospan has transformed treatment of life-threatening Aortic Arch Disease from a high-risk open surgery
into a minimally invasive aortic arch repair, including aneurysms and dissections.
Endospan's mission is to develop innovative products that significantly advance the treatment of aortic instability. NEXUS™ Stent Graft System is the first branched off-the-shelf endovascular system to treat Aortic Arch Disease, a greatly underserved patient population.
What are Experts Are Saying About NEXUS™ ?
Ross Milner, MD
Director, Center for Aortic Diseases;
University of Chicago Medicine
Thomas Lindsay, MD
Chief, Vascular Surgery;
Toronto General Hospital
Andrew Holden, MD
Associate Professor of Radiology;
Auckland (NZ) University
School of Medicine